BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27801764)

  • 21. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
    Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
    Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium.
    Stewart CJ; Little L
    Pathology; 2010 Apr; 42(3):217-23. PubMed ID: 20350213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
    Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
    Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS.
    Witkiewicz A; Lee KR; Brodsky G; Cviko A; Brodsky J; Crum CP
    Am J Surg Pathol; 2005 Dec; 29(12):1609-14. PubMed ID: 16327433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
    Little L; Stewart CJ
    Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
    Chekmareva M; Ellenson LH; Pirog EC
    Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
    Roma AA; Goyal A; Yang B
    Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
    He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
    Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial Gastric (Gastrointestinal)-type Mucinous Lesions: Report of a Series Illustrating the Spectrum of Benign and Malignant Lesions.
    Wong RW; Ralte A; Grondin K; Talia KL; McCluggage WG
    Am J Surg Pathol; 2020 Mar; 44(3):406-419. PubMed ID: 31567280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
    McCluggage WG; Jenkins D
    Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
    Mikami Y; Kiyokawa T; Hata S; Fujiwara K; Moriya T; Sasano H; Manabe T; Akahira J; Ito K; Tase T; Yaegashi N; Sato I; Tateno H; Naganuma H
    Mod Pathol; 2004 Aug; 17(8):962-72. PubMed ID: 15143335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
    Samarawardana P; Singh M; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):514-8. PubMed ID: 21602668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
    Chung T; DO SI; Na K; Kim G; Jeong YI; Kim YW; Kim HS
    Anticancer Res; 2018 Jun; 38(6):3551-3558. PubMed ID: 29848709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust expression of EZH2 in endocervical neoplastic lesions.
    Makk E; Bálint L; Cifra J; Tornóczky T; Oszter A; Tóth A; Kálmán E; Kovács K
    Virchows Arch; 2019 Jul; 475(1):95-104. PubMed ID: 30903272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.